BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

Happiness Biotech Announced The Launch of Its Lucidum Tablets

"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...

September 13, 2021 | News

Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech

Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharm...

September 09, 2021 | News

Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate

With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of slee...

September 08, 2021 | News

GeneQuantum ,BrighGene to develop antibody immune agonist conjugates

GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...

September 07, 2021 | News

Insilico Medicine & 4B Technologies to advance the development of innovative small molecule therapies

Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and 4B Technologies Co., Ltd. ("4B ...

August 30, 2021 | News

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide to treat Covid19

Pursuant to the Licensing Agreement, Kintor Pharma will receive from Etana upfront and milestone payments, in addition to the economic benefit relating to ...

August 26, 2021 | News

Study Confirms Viraleze Provides Protection Against SARS-CoV-2

The findings, published in the peer-reviewed journal Viruses, in a special issue titled Medical Interventions for Treatment and Prevention of SAR...

August 24, 2021 | News

Standigm Expands Global Footprints with New Office in Cambridge, UK

Founded in 2015, Standigm has proprietary technology including AI platforms encompassing novel target identification to novel compound design to generate c...

August 20, 2021 | News

Daewoong Pharma, Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Bio...

August 20, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

August 19, 2021 | News

India's first nasal vaccine for COVID-19 receives nod for Phase 2, 3 trial

India's first nasal vaccine, developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Rese...

August 16, 2021 | News

InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332

InnoCare discovered and developed the oral drug candidate ICP-332. As a non-receptor tyrosine kinase, TYK2 is a member of the JAK kinase family, which is a...

August 16, 2021 | News

NUHS Embarks on Holomedicine Research in Singapore

To be able to literally "see inside" a patient's skull and identify the location of the tumour deep in the brain, right on the operating table, may no long...

August 13, 2021 | News

Stay Connected